Market
Nektar Therapeutics NKTR’s stock price falss traction on Monday
In Monday's session, Nektar Therapeutics (NASDAQ:NKTR) marked $0.57 per share, down from $0.60 in the previous session. While Nektar Therapeutics...
Read more
EVgo Inc (EVGO) stock analysis: A comprehensive overview
In Monday's session, EVgo Inc (NASDAQ:EVGO) marked $3.20 per share, down from $3.38 in the previous session. While EVgo Inc...
Read more
Ocugen Inc (OCGN) stock on the rise: An overview
Ocugen Inc (NASDAQ:OCGN) closed Monday at $0.40 per share, up from $0.40 a day earlier. While Ocugen Inc has overperformed...
Read more
Semtech Corp. (SMTC) deserves deeper analysis
In Monday's session, Semtech Corp. (NASDAQ:SMTC) marked $25.21 per share, down from $25.75 in the previous session. While Semtech Corp....
Read more
A year in review: Madrigal Pharmaceuticals Inc (MDGL)’s performance in the last year
The share price of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) fell to $143.36 per share on Monday from $146.04. While Madrigal Pharmaceuticals...
Read more
Are Guardant Health Inc’shares a good deal?
Guardant Health Inc (NASDAQ:GH) closed Monday at $29.18 per share, down from $29.64 a day earlier. While Guardant Health Inc...
Read more
Should investors be concerned about Zeta Global Holdings Corp (ZETA)?
The share price of Zeta Global Holdings Corp (NYSE:ZETA) fell to $8.14 per share on Monday from $8.35. While Zeta...
Read more
Honest Company Inc (HNST) shows promising results
In Monday's session, Honest Company Inc (NASDAQ:HNST) marked $1.25 per share, down from $1.26 in the previous session. While Honest...
Read more
It would be worthwhile to take a closer look at Terns Pharmaceuticals Inc (TERN)
The share price of Terns Pharmaceuticals Inc (NASDAQ:TERN) fell to $4.91 per share on Monday from $5.03. While Terns Pharmaceuticals...
Read more
Is it possible to buy NextDecade Corporation(NEXT) shares at a good price now?
NextDecade Corporation (NASDAQ:NEXT) closed Monday at $4.88 per share, down from $5.12 a day earlier. While NextDecade Corporation has underperformed...
Read more
